Main public logs
Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 08:46, 21 March 2024 Fire talk contribs created page Translations:Insulin glargine/17/ja (Created page with "===作用機序=== インスリングラルギンは、ヒトインスリンとは異なり、A鎖の21位のアスパラギンをグリシンに置換し、B鎖のカルボキシ末端を2残基のアルギニン残基で延長している。 アルギニンアミノ酸は等電点をpH5.4から6.7にシフトさせ、分子を酸性pHでより溶けやすく、生理的pHでは溶けにくくする。等電点シフトはまた、透明な溶液の皮下注射を可能...")
- 11:15, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/22/ja (Created page with "== 社会と文化 == {{Anchor|Society and culture}} === 法的地位 === ==== バイオシミラー ==== アバサグラーは2014年9月に欧州連合(EU)で医薬品として承認された。")
- 11:15, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/16/ja (Created page with "==薬理学== {{Anchor|Pharmacology}}")
- 11:14, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/15/ja (Created page with "インスリングラルギンをNPHインスリン、インスリンデテミル、インスリンデグルデクと比較した場合、6ヵ月以上の期間において、成人、小児ともにI型糖尿病の管理に有意な副作用は認められなかった。")
- 11:14, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/14/ja (Created page with "2012年現在、インスリングラルギンと癌との間に関連性はないという暫定的な証拠が示されている。以前の研究では懸念が指摘されていた。")
- 11:14, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/13/ja (Created page with "==副作用== {{Anchor|Adverse effects}} 一般的な副作用には、低血糖、注射部位の問題、かゆみ、体重増加などがある。重篤な副作用には低血中カリウムがある。")
- 11:13, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/12/ja (Created page with "===他のインスリンとの混合=== 他の長時間作用型インスリン製剤と異なり、グラルギンは希釈したり、他のインスリン製剤や溶液と同じシリンジ内で混合してはならない。しかし、この制限は疑問視されている。")
- 11:13, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/11/ja (Created page with "セムグリー(Semglee)は、成人および小児の1型糖尿病患者ならびに成人の2型糖尿病患者における血糖コントロール改善を適応症としている。セムグリーは、長時間作用型インスリンアナログである参照製品ランタス(インスリングラルギン)とバイオシミラーであり、互換性がある(代替可能である)。")
- 11:13, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/10/ja (Created page with "==医薬用途== {{Anchor|Medical uses}} インスリングラルギンを含む長時間作用型インスリンクラスは、NPH(neutral protamine Hagedorn)インスリンよりもはるかに優れているようには見えないが、コストが高いため、2010年現在、2型糖尿病の治療には費用対効果がない。以前のレビューでは、長期的な転帰に関して違いを判断するのに十分なデータがなか...")
- 11:06, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/26/ja (Created page with "==== 特許失効 ==== インスリングラルギンの特許は2015年にほとんどの国で失効し、米国では2027-07-05に失効する見込みである。競合薬であるEli Lillyのインスリングラルギンは、バサグラー(米国では後続品)、アバサグラー(EUではバイオシミラー)という商品名で、2015年中にほとんどの国で入手可能となった。")
- 11:06, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/9/ja (Created page with "<!-- Society and culture --> インスリングラルギンは、2000年に米国で医薬品として承認された。世界保健機関の必須医薬品リストに掲載されている。2021年には、19{{nbsp}}万件以上の処方で、米国で29番目に多く処方されている医薬品であった。2021年7月、米国食品医薬品局(FDA)は、糖尿病治療用のセ...")
- 11:05, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/8/ja (Created page with "<!-- Side effects and mechanism --> 一般的な副作用には、低血糖、注射部位の問題、かゆみ、体重増加などがある。その他の重篤な副作用には低血中カリウムがある。インスリングラルギンよりもむしろNPHインスリンが一般的に妊婦で好まれる。注射後、微結晶は約24時間ゆっくりと...")
- 11:03, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/27/ja (Created page with "{{Oral hypoglycemics and insulin analogs}} {{Eli Lilly and Company/ja}} {{Portal bar | Medicine}}")
- 11:03, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/28/ja (Created page with "{{DEFAULTSORT:Insulin Glargine}} Category:Insulin receptor agonists Category:Human proteins Category:Recombinant proteins Category:Peptide hormones Category:Peptide therapeutics Category:Wikipedia medicine articles ready to translate Category:Drugs developed by Eli Lilly and Company Category:Drugs developed by Boehringer Ingelheim Category:Sanofi Category:World Health Organization essential medicines")
- 11:03, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/7/ja (Created page with "<!-- Definition and medical uses --> '''ランタス'''などの商品名で販売されている'''インスリングラルギン'''は、医療用インスリンの長時間作用型改良型であり、Ⅰ型糖尿病および2型糖尿病の管理に用いられる。皮膚のすぐ下に注射する。効果は一般に使用後1時間で始ま...")
- 11:02, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/6/ja (Created page with "<!-- Chemical and physical data --> | IUPAC_name = Recombinant human insulin | C=267 | H=404 | N=72 | O=78 | S=6 | SMILES = | Jmol = | StdInChI = | StdInChI_comment = | StdInChIKey = | density = | density_notes = | melting_point = | melting_high = | melting_notes = | boiling_point = | boiling_notes = | solubility = | sol_units = | specific_rotation = }}")
- 11:02, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/5/ja (Created page with "<!-- Identifiers --> | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 160337-95-1 | CAS_supplemental = | PubChem = | IUPHAR_ligand = 7572 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00047 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = none | UNII_Ref = {{fdacite|changed|FDA}} | UNII = 2ZM8CX04RZ | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D03250 | ChEBI_Ref = | ChEBI = | ChEMBL_...")
- 11:02, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/4/ja (Created page with "<!-- Pharmacokinetic data --> | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = ~1 hours | elimination_half-life = | duration_of_action = 24から36時間 | excretion =")
- 11:02, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/3/ja (Created page with "<!-- Legal status --> | legal_AU = S4 | legal_AU_comment = | legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F --> | legal_BR_comment = | legal_CA = Rx-only | legal_CA_comment = /{{nbsp}}Schedule D | legal_DE = <!-- Anlage I, II, III or Unscheduled --> | legal_DE_comment = | legal_NZ = <!-- Class A, B, C --> | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal...")
- 11:02, 20 March 2024 Fire talk contribs created page Insulin glargine/ja (Created page with "<!-- Clinical data --> | pronounce = | tradename = Lantus, Toujeo, Basaglar, others | Drugs.com = {{drugs.com|monograph|insulin_glargine}} | MedlinePlus = a600027 | DailyMedID = Insulin_glargine | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = 皮下 | class = | ATCvet = | ATC_prefix = A10 | ATC_suffix = AE04 | ATC_supplemental = | biosimilars = insul...") Tags: Mobile edit Mobile web edit
- 11:02, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/2/ja (Created page with "<!-- Clinical data --> | pronounce = | tradename = Lantus, Toujeo, Basaglar, others | Drugs.com = {{drugs.com|monograph|insulin_glargine}} | MedlinePlus = a600027 | DailyMedID = Insulin_glargine | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = 皮下 | class = | ATCvet = | ATC_prefix = A10 | ATC_suffix = AE04 | ATC_supplemental = | biosimilars = insul...")
- 11:01, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/1/ja (Created page with "{{Infobox drug | Verifiedfields = changed | verifiedrevid = 458271727 | image = Toujeo 300 IU-ml inj.jpg | width = | alt = | caption = Toujeoブランドのインスリングラルギン")
- 11:01, 20 March 2024 Fire talk contribs created page Translations:Insulin glargine/Page display title/ja (Created page with "インスリングラルギン")
- 11:01, 20 March 2024 FuzzyBot talk contribs created page Insulin glargine/en (Updating to match new version of source page) Tags: Mobile edit Mobile web edit
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/28/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/27/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/26/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/25/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/24/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/23/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/22/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/21/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/20/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/19/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/18/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/17/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/16/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/15/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/14/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/13/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/12/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/11/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/10/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/9/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/8/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/7/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/6/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/5/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/4/en (Importing a new version from external source)
- 11:00, 20 March 2024 FuzzyBot talk contribs created page Translations:Insulin glargine/3/en (Importing a new version from external source)